3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Lymphoma, B-Cell
17
Lymphoma, Large B-Cell, Diffuse
16
Lymphoma, Non-Hodgkin
12
Recurrence
11
Burkitt Lymphoma
10
Multiple Myeloma
7
Lymphoma
7
Neoplasms
6
Leukemia, Myeloid, Acute
6
Lymphoma, Mantle-Cell
5
Leukemia
5
Pancreatic Neoplasms
4
Lymphoma, Follicular
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Hematologic Neoplasms
4
Carcinoma, Hepatocellular
4
Neoplasm, Residual
3
Nasopharyngeal Carcinoma
3
Leukemia, B-Cell
3
Glioma
3
Colorectal Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Simpson-Golabi-Behmel syndrome
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Osteosarcoma
2
Melanoma
2
Lymphoma, B-Cell, Marginal Zone
2
Interventions
Cyclophosphamide
26
fludarabine
16
Etoposide
15
Melphalan
13
romidepsin
12
Gemcitabine
11
Whole-Body Irradiation
10
Vincristine
10
Peripheral Blood Stem Cell Transplantation
10
Doxorubicin
10
fludarabine phosphate
9
Rituximab
9
Lenalidomide
9
Cytarabine
9
Busulfan
9
pembrolizumab
8
Prednisone
8
Mycophenolic Acid
8
Granulocyte Colony-Stimulating Factor
8
Bortezomib
8
Filgrastim
7
Carmustine
7
Brentuximab Vedotin
7
Biopsy
7
duvelisib
6
Tacrolimus
6
Specimen Handling
6
Dexamethasone
6
Bendamustine Hydrochloride
6
ruxolitinib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lymphoma, T-Cell
×
Immunotherapy, Adoptive
×
Clear all
NCT01685606
2022-03-04
273
Brown University
Phase 2
Terminated
6 enrolled
7 charts